{"id":17410,"date":"2021-11-17T07:19:48","date_gmt":"2021-11-17T15:19:48","guid":{"rendered":"https:\/\/ameripharmaspe.wpengine.com\/?p=17410"},"modified":"2026-03-20T14:32:52","modified_gmt":"2026-03-20T21:32:52","slug":"olaparib-lynparza","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/","title":{"rendered":"Olaparib (Lynparza)"},"content":{"rendered":"\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#What_Is_Olaparib\" >What Is Olaparib?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#What_Is_Targeted_Therapy\" >What Is Targeted Therapy?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#Handling_Precautions\" >Handling Precautions<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#How_Is_Lynparza_Used\" >How Is Lynparza Used?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#Available_Formulations\" >Available Formulations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#Directions_for_Use\" >Directions for Use<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#Missed_Dose\" >Missed Dose<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#Storage\" >Storage<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#What_To_Avoid_While_Taking_Lynparza\" >What To Avoid While Taking Lynparza<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#Pregnancy_and_Lynparza\" >Pregnancy and Lynparza<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#Side_Effects\" >Side Effects<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#Lung_Problems\" >Lung Problems&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#Secondary_Malignancies\" >Secondary Malignancies<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#Cardiac_Complications\" >Cardiac Complications<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#Allergic_Reaction\" >Allergic Reaction<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#Urinary_Tract_Infection_UTI\" >Urinary Tract Infection (UTI)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#Bone_Marrow_Suppression\" >Bone Marrow Suppression<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#Precautions\" >Precautions<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/#FAQs\" >FAQs<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Olaparib\"><\/span>What Is Olaparib?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Olaparib (pronounced [oh LAP a rib]) is also known by the brand name, Lynparza. It is an antineoplastic (anticancer) drug that belongs to a class called <a href=\"https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/parp-inhibitor\">PARP inhibitors<\/a>, and it may be prescribed alone or in combination with other anticancer drugs like bevacizumab (<a href=\"https:\/\/ameripharmaspecialty.com\/discontinued\/bevacizumab-avastin\/\">Avastin<\/a>). Lynparza is a <strong>targeted anticancer therapy<\/strong> (a PARP inhibitor). It is not considered traditional cytotoxic chemotherapy.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-1c826a459088d44a41d01ece23edd617\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tSpeak to a Chemo Specialist\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Targeted_Therapy\"><\/span><strong>What Is Targeted Therapy?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Targeted therapy is a cancer treatment designed to affect specific pathways cancer cells use to grow and survive. PARP inhibitors like olaparib work by interfering with DNA repair , which can help slow or stop tumor growth in cells.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Handling_Precautions\"><\/span><strong>Handling Precautions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Olaparib is considered to be a hazardous agent, and normally, these pills are covered by a thin coating of material. If this coating is damaged, removed, melted, or if the pill is broken into pieces, the chemical inside the pill can cause damage to your skin if you touch it. Therefore, it is important to take appropriate precautions for receiving, handling, storing, administering, and disposing of this medication. Wear gloves if touching this medication, or avoid touching it entirely by using the cap of the bottle to scoop up the tablet and put it directly into the mouth. <\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Is_Lynparza_Used\"><\/span>How Is Lynparza Used?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Lynparza has been approved by the Food and Drug Administration (FDA) to treat a wide variety of cancers, including breast, ovarian, pancreatic, prostate, and other cancers. It can be prescribed in combination with <a href=\"https:\/\/ameripharmaspecialty.com\/cancer\/rituximab-rituxan\/\">other chemotherapy agents<\/a>, depending on the severity and type of cancer. <\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Available_Formulations\"><\/span>Available Formulations<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Lynparza is only available in the form of tablets or capsules and must be administered orally. The tablets are only available in two strengths: 100 mg and 150 mg. The capsules, on the other hand, are only available in 50 mg strength. The tablets are elliptical or oval-shaped. The 100 mg tablet is yellow with \u201cOP 100\u201d imprinted on one side. The 150 mg tablet is green with \u201cOP 150\u201d imprinted on one side. The capsules are white and marked with \u201cOlaparib 50 mg,\u201d followed by a logo. <\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Directions_for_Use\"><\/span>Directions for Use<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Lynparza may be taken with or without food. When taking the pill, swallow it whole; do not break, crush, chew, open, or allow it to be dissolved in your mouth. Do not substitute capsules for tablets without consulting with your physician. Lynparza is typically dosed twice a day, and the dose is dependent on the cancer type and severity. Verify the correct dose and frequency with your provider. <\/span><\/p>\n\n\n\n<p>The duration of Olaparib therapy is highly individualized and depends on the specific cancer type, stage, and response to treatment. In some settings, it may be taken for a defined period, while in others, it is taken until disease progression or unacceptable toxicity.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Missed_Dose\"><\/span>Missed Dose<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">If you accidentally miss a dose, skip the missed dose and continue with the next scheduled dose. Do not take extra doses to make up for a missed dose.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Storage\"><\/span>Storage<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Store Lynparza tablets in a cool, dry place at room temperature and keep the bottle tightly closed.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-feb83fd205792b48c3e52ccf3b131d62\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tSpeak to a Specialist About Copay Assistance\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Consult a Chemo Specialist<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_To_Avoid_While_Taking_Lynparza\"><\/span>What To Avoid While Taking Lynparza<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">While on the Lynparza therapy, you must follow some precautions. Always tell your physician about any medications you are already taking. <\/span><b>Do not take any drug or medicine (even herbals or over-the-counter medications) without prior consent from your physician or pharmacist, as they may have significant interactions with Lynparza<\/b><span style=\"font-weight: 400;\">. Avoid grapefruit, grapefruit juice,&nbsp; Seville orange juice, and Seville oranges throughout therapy as they may also interact with this medication.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Pregnancy_and_Lynparza\"><\/span>Pregnancy and Lynparza<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Pregnancy status should be checked prior to starting treatment in women of childbearing age. Females of childbearing age must use effective contraception during treatment and for 6 months after the last dose. Male patients with partners who can become pregnant should use effective contraception during treatment and for 3 months after the last dose. Lynparza may cause fetal harm and is therefore not recommended for women who are breastfeeding during therapy. Breastfeeding should also be avoided for at least 1 month after the last dose.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Side_Effects\"><\/span>Side Effects<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">As with any other medication, you may encounter many side effects while taking Lynparza. A few things to keep in mind are:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">You may not have all the side effects listed below. Many people may experience little to no side effects.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">The severity of side effects may vary from person to person, so don&#8217;t compare your side effects with other people\u2019s experiences.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Most of the side effects will improve when therapy is discontinued.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">These side effects are easily manageable most of the time, either by readjusting the dose of Lynparza or using additional medications to treat the symptoms. Consult with your physician or pharmacist to explore available options.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Do not hide any symptoms; when you feel any discomfort, do not hesitate to tell your physician or pharmacist about it.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<p><strong>Note<\/strong>: This is not a comprehensive list of all side effects. Talk to your doctor if you have questions. Some side effects are common and manageable, while others are rare but serious \u2014 your care team can help you understand your individual risk.<\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Some of the most common side effects of Lynparza are:&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Lung_Problems\"><\/span><span style=\"font-weight: 400;\">Lung Problems&nbsp;<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Lung complications like <a href=\"https:\/\/www.medicalnewstoday.com\/articles\/319451\">pneumonitis<\/a> may occur. Contact a physician or get emergency medical help right away if you have shortness of breath with or without a fever, cough, trouble breathing, or a fast rate of breathing.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Secondary_Malignancies\"><\/span><span style=\"font-weight: 400;\">Secondary Malignancies<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Rarely, treatment with Lynparza has been associated with serious blood disorders such as myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Tell your provider right away if you develop unusual fatigue, frequent infections, easy bruising\/bleeding, or persistent fevers.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cardiac_Complications\"><\/span><span style=\"font-weight: 400;\">Cardiac Complications<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Blood clots (such as deep vein thrombosis or pulmonary embolism) have been reported in some patients taking Lynparza, particularly in those being treated for prostate cancer. Seek urgent medical care if you have symptoms of a clot.&nbsp; Clots may present as chest pain or pressure, coughing up blood, shortness of breath, swelling, warmth, numbness, change of color, or pain in a leg or arm, or trouble speaking or swallowing.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-3097e9134292c8b60bc387a1bea885ec\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tGet Chemotherapy Copay Assistance\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tChemotherapy\u00a0Financial Assistance\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Allergic_Reaction\"><\/span><span style=\"font-weight: 400;\">Allergic Reaction<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Lynparza can cause hypersensitivity reactions that can include rash, dermatitis, and angioedema. Notify your physician or pharmacist immediately of any signs of a rash or allergic reaction, including wheezing; tightness in the chest or throat; hives, blistered or peeling skin; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Urinary_Tract_Infection_UTI\"><\/span><span style=\"font-weight: 400;\">Urinary Tract Infection (UTI)<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">A <a href=\"https:\/\/my.clevelandclinic.org\/health\/diseases\/9135-urinary-tract-infections\">UTI<\/a> may occur in certain situations. If symptoms like blood in the urine, burning or painful urination, passing a lot of urine, fever, lower abdominal pain, or pelvic pain are present, consult your physician.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Bone_Marrow_Suppression\"><\/span><span style=\"font-weight: 400;\">Bone Marrow Suppression<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">It is essential to keep up with regular blood tests, especially the complete blood count test (CBC). The CBC blood test is capable of detecting potential side effects of Lynparza, including leukopenia (low white blood cell levels), thrombocytopenia (low platelet count), neutropenia (low neutrophils, a type of white blood cell), and anemia (low red blood cells). This blood work is typically required every month, or as often as your healthcare provider instructs, for the first year of therapy and periodically thereafter.<\/span><\/p>\n\n\n\n<p><b>Less severe side effects<\/b> <b>can include:<\/b><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Nausea<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Fatigue, dizziness, tiredness, or weakness<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Vomiting<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Diarrhea<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Constipation<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Common cold symptoms<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Muscle or joint pain<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Nose or throat irritation<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Change in taste<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Abdominal pain<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Loss of appetite or weight loss<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Precautions\"><\/span>Precautions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Unless approved by your physician, Lynparza is generally not recommended in:&nbsp;<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Patients who have an allergy to Lynparza. Allergic reactions can cause a rash over the whole body, shortness of breath, wheezing, dizziness, swelling around the mouth or eyes, fast heart rate, trouble breathing, and sweating. If you have any of these symptoms, stop using Lynparza and call your doctor or get emergency help right away.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Patients with a history of lung disease or if pneumonitis develops. Discontinuation of therapy may be required if pneumonitis is confirmed<\/span><\/li>\n<\/ul>\n\n\n\n<div  id=\"call-to-action-0497e1acbede338763ab03193684d2c5\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tConsult a Chemotherapy Specialist\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tGet Chemotherapy Treatment Assistance\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Schedule a Consultation<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs\"><\/span>FAQs<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h4 class=\"wp-block-heading\">Is Lynparza a chemo agent?<\/h4>\n\n\n\n<p><span style=\"font-weight: 400;\">Lynparza is a targeted therapy (PARP inhibitor). While it is an anticancer drug, it is not classified as traditional <a href=\"https:\/\/ameripharmaspecialty.com\/cancer\/acalabrutinib-calquence\/\">chemotherapy<\/a>.<\/span><\/p>\n\n\n\n<h4 class=\"wp-block-heading\">How should Lynparza be taken?<\/h4>\n\n\n\n<p><span style=\"font-weight: 400;\">Take Lynparza exactly as prescribed,&nbsp; <strong>twice daily<\/strong>. Swallow tablets whole and do not crush or chew them. If you have questions about your specific dose or schedule, contact your healthcare provider.<\/span><\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Is olaparib available as a generic?<\/h4>\n\n\n\n<p><span style=\"font-weight: 400;\">Currently, olaparib is not available as a generic. It is only available as the brand, Lynparza.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Olaparib (pronounced [oh LAP a rib]) is also known by the brand name, Lynparza. It is an antineoplastic (anticancer) drug that belongs to a class called PARP inhibitors, and it may be prescribed alone or in combination with other anticancer drugs like bevacizumab (Avastin).<\/p>\n","protected":false},"author":11,"featured_media":17693,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[13],"tags":[11],"class_list":["post-17410","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","tag-dr-dania-jaradat"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Olaparib (Lynparza) - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Olaparib (Lynparza) is an anticancer drug that belongs to a class called PARP inhibitors. It is a type of chemotherapy and it may be prescribed alone or in combination with other anticancer drugs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Olaparib (Lynparza) - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Olaparib (Lynparza) is an anticancer drug that belongs to a class called PARP inhibitors. It is a type of chemotherapy and it may be prescribed alone or in combination with other anticancer drugs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-17T15:19:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-20T21:32:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Dania Jaradat, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Dania Jaradat, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/cancer\\\/olaparib-lynparza\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/cancer\\\/olaparib-lynparza\\\/\"},\"author\":{\"name\":\"Dr. Dania Jaradat, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/0b5942aa9b36880a9c10fe4d05765fb1\"},\"headline\":\"Olaparib (Lynparza)\",\"datePublished\":\"2021-11-17T15:19:48+00:00\",\"dateModified\":\"2026-03-20T21:32:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/cancer\\\/olaparib-lynparza\\\/\"},\"wordCount\":1394,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/cancer\\\/olaparib-lynparza\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/lynparza.jpg\",\"keywords\":[\"Dr. Dania Jaradat\"],\"articleSection\":[\"Cancer\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/cancer\\\/olaparib-lynparza\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/cancer\\\/olaparib-lynparza\\\/\",\"name\":\"Olaparib (Lynparza) - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/cancer\\\/olaparib-lynparza\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/cancer\\\/olaparib-lynparza\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/lynparza.jpg\",\"datePublished\":\"2021-11-17T15:19:48+00:00\",\"dateModified\":\"2026-03-20T21:32:52+00:00\",\"description\":\"Olaparib (Lynparza) is an anticancer drug that belongs to a class called PARP inhibitors. It is a type of chemotherapy and it may be prescribed alone or in combination with other anticancer drugs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/cancer\\\/olaparib-lynparza\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/cancer\\\/olaparib-lynparza\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/cancer\\\/olaparib-lynparza\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/lynparza.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/lynparza.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Lynparza\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/cancer\\\/olaparib-lynparza\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Olaparib (Lynparza)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/0b5942aa9b36880a9c10fe4d05765fb1\",\"name\":\"Dr. Dania Jaradat, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/09de97a6e62734df4714c2dff23ab972732a5a4696fb5fecd6a634fff30302f7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/09de97a6e62734df4714c2dff23ab972732a5a4696fb5fecd6a634fff30302f7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/09de97a6e62734df4714c2dff23ab972732a5a4696fb5fecd6a634fff30302f7?s=96&d=mm&r=g\",\"caption\":\"Dr. Dania Jaradat, PharmD\"},\"description\":\"Dr. Dania Jaradat, PharmD was born and raised in Torrance, California. She graduated from Marshall B. Ketchum University. The most rewarding part of her job is to keep the line between pharmacist and patient open and to educate patients on medication management. In her free time, she enjoys traveling to different countries, spending time with her husband and son, and reading. See Author Biography\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/dania-jaradat\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Olaparib (Lynparza) - AmeriPharma\u00ae Atenci\u00f3n especializada","description":"Olaparib (Lynparza) es un f\u00e1rmaco anticancer\u00edgeno que pertenece a la clase de inhibidores de PARP. Es un tipo de quimioterapia y puede recetarse solo o en combinaci\u00f3n con otros f\u00e1rmacos anticancer\u00edgenos.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/","og_locale":"es_MX","og_type":"article","og_title":"Olaparib (Lynparza) - AmeriPharma\u00ae Specialty Care","og_description":"Olaparib (Lynparza) is an anticancer drug that belongs to a class called PARP inhibitors. It is a type of chemotherapy and it may be prescribed alone or in combination with other anticancer drugs.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/cancer\/olaparib-lynparza\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2021-11-17T15:19:48+00:00","article_modified_time":"2026-03-20T21:32:52+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg","type":"image\/jpeg"}],"author":"Dr. Dania Jaradat, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Dania Jaradat, PharmD","Est. reading time":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/olaparib-lynparza\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/olaparib-lynparza\/"},"author":{"name":"Dr. Dania Jaradat, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/0b5942aa9b36880a9c10fe4d05765fb1"},"headline":"Olaparib (Lynparza)","datePublished":"2021-11-17T15:19:48+00:00","dateModified":"2026-03-20T21:32:52+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/olaparib-lynparza\/"},"wordCount":1394,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/olaparib-lynparza\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg","keywords":["Dr. Dania Jaradat"],"articleSection":["Cancer"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/olaparib-lynparza\/","url":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/olaparib-lynparza\/","name":"Olaparib (Lynparza) - AmeriPharma\u00ae Atenci\u00f3n especializada","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/olaparib-lynparza\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/olaparib-lynparza\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg","datePublished":"2021-11-17T15:19:48+00:00","dateModified":"2026-03-20T21:32:52+00:00","description":"Olaparib (Lynparza) es un f\u00e1rmaco anticancer\u00edgeno que pertenece a la clase de inhibidores de PARP. Es un tipo de quimioterapia y puede recetarse solo o en combinaci\u00f3n con otros f\u00e1rmacos anticancer\u00edgenos.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/olaparib-lynparza\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/vi\/cancer\/olaparib-lynparza\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/olaparib-lynparza\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg","width":1280,"height":853,"caption":"Lynparza"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/vi\/cancer\/olaparib-lynparza\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/vi\/"},{"@type":"ListItem","position":2,"name":"Olaparib (Lynparza)"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/0b5942aa9b36880a9c10fe4d05765fb1","name":"Dra. Dania Jaradat, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/09de97a6e62734df4714c2dff23ab972732a5a4696fb5fecd6a634fff30302f7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/09de97a6e62734df4714c2dff23ab972732a5a4696fb5fecd6a634fff30302f7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/09de97a6e62734df4714c2dff23ab972732a5a4696fb5fecd6a634fff30302f7?s=96&d=mm&r=g","caption":"Dr. Dania Jaradat, PharmD"},"description":"La Dra. Dania Jaradat, doctora en farmacia, naci\u00f3 y creci\u00f3 en Torrance, California. Se gradu\u00f3 de la Universidad Marshall B. Ketchum. Lo m\u00e1s gratificante de su trabajo es mantener la comunicaci\u00f3n fluida entre el farmac\u00e9utico y el paciente, y educar a estos sobre el manejo de sus medicamentos. En su tiempo libre, disfruta viajando a diferentes pa\u00edses, pasando tiempo con su esposo e hijo, y leyendo. Ver biograf\u00eda de la autora.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/dania-jaradat\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Dania Jaradat, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/dania-jaradat\/"},"uagb_comment_info":1,"uagb_excerpt":"Olaparib (pronounced [oh LAP a rib]) is also known by the brand name, Lynparza. It is an antineoplastic (anticancer) drug that belongs to a class called PARP inhibitors, and it may be prescribed alone or in combination with other anticancer drugs like bevacizumab (Avastin).","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2021\/11\/lynparza.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Dania Jaradat, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/dania-jaradat\/"},"rttpg_comment":1,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/cancer\/\" rel=\"category tag\">Cancer<\/a>","rttpg_excerpt":"Olaparib (pronounced [oh LAP a rib]) is also known by the brand name, Lynparza. It is an antineoplastic (anticancer) drug that belongs to a class called PARP inhibitors, and it may be prescribed alone or in combination with other anticancer drugs like bevacizumab (Avastin).","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/17410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=17410"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/17410\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/17693"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=17410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=17410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=17410"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}